These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 8685953)
1. Additional inhibitory effects of intravenous immunoglobulins in combination with cyclosporine A on human T lymphocyte alloproliferative response in vitro. Schanz U; Hügle T; Gmür J Transplantation; 1996 Jun; 61(12):1736-40. PubMed ID: 8685953 [TBL] [Abstract][Full Text] [Related]
2. Synergistic and antagonistic effects of combinations of cyclosporine A and its metabolites on inhibition of phytohemagglutinin-induced lymphocyte transformation in vitro. Schultz JC; Lensmeyer GL; Wendal TD; Shahidi NT; Wiebe DA; Carlson IH Biochem Pharmacol; 1991 Sep; 42(7):1403-10. PubMed ID: 1834063 [TBL] [Abstract][Full Text] [Related]
3. Activation of PPARgamma enhances in vitro the immunosuppressive effect of cyclosporine on T lymphocytes. Rampino T; Ranghino A; Guidetti C; Gregorini M; Soccio G; Marasà M; Libetta C; Guida G; De Amici M; Dal Canton A Transpl Immunol; 2007 Jul; 18(1):32-6. PubMed ID: 17584600 [TBL] [Abstract][Full Text] [Related]
4. Synergistic inhibitory effect of cyclosporin A and vitamin D derivatives on T-lymphocyte proliferation in active ulcerative colitis. Stio M; Treves C; Celli A; Tarantino O; d'Albasio G; Bonanomi AG Am J Gastroenterol; 2002 Mar; 97(3):679-89. PubMed ID: 11922564 [TBL] [Abstract][Full Text] [Related]
5. Comparative Inhibitory Effects of Tacrolimus, Cyclosporine, and Rapamycin on Human Anti-Pig Xenogeneic Mixed Lymphocyte Reactions. Zhang M; Feng H; Du J; Chen S; Zhu L; Wang Y; Pan D; Chen G Xenotransplantation; 2024; 31(4):e12876. PubMed ID: 39031102 [TBL] [Abstract][Full Text] [Related]
6. Human T cell responses to human and porcine endothelial cells are highly sensitive to cyclosporin A and FK506 in vitro. Batten P; McCormack AM; Page CS; Yacoub MH; Rose ML Transplantation; 1999 Nov; 68(10):1552-60. PubMed ID: 10589954 [TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus. Wang ME; Tejpal N; Qu X; Yu J; Okamoto M; Stepkowski SM; Kahan BD Transplantation; 1998 Apr; 65(7):899-905. PubMed ID: 9565092 [TBL] [Abstract][Full Text] [Related]
8. A comparison of the immunosuppressive effects of cyclosporine A and cyclosporine G in vivo and in vitro. Rayat G; Yatscoff R; Silverman R; McKenna R Transplantation; 1993 Mar; 55(3):623-6. PubMed ID: 8456482 [TBL] [Abstract][Full Text] [Related]
10. Strong additive effect of calcitriol and cyclosporine A on lymphocyte proliferation in vitro and rat liver allotransplantations in vivo. Zhang AB; Zheng SS Chin Med J (Engl); 2006 Dec; 119(24):2090-5. PubMed ID: 17199961 [TBL] [Abstract][Full Text] [Related]
11. Direct inhibition of human CD8+ lymphocyte activation by cyclosporine A and Rapamune-Sirolimus. Combates NJ; Degiannis D; Raskova J; Raska K Clin Immunol Immunopathol; 1995 Dec; 77(3):221-8. PubMed ID: 7586731 [TBL] [Abstract][Full Text] [Related]
12. A comparison of the inhibitory effects of immunosuppressive agents cyclosporine, tetranactin, and didemnin B on human T cell responses in vitro. Teunissen MB; Pistoor FH; Rongen HA; Kapsenberg ML; Bos JD Transplantation; 1992 Apr; 53(4):875-81. PubMed ID: 1566353 [TBL] [Abstract][Full Text] [Related]
13. Cytokines and cell surface receptors as target end points of immunosuppression with cyclosporine A. Sindhi R; Allaert J; Gladding D; Koppelman B; Dunne JF J Interferon Cytokine Res; 2001 Jul; 21(7):507-14. PubMed ID: 11506745 [TBL] [Abstract][Full Text] [Related]
14. Corticosteroids do not reverse the inhibitory effect of cyclosporine on regulatory T-cell activity in contrast to mycophenolate mofetil. Miroux C; Morales O; Ouaguia L; Aoudjehane L; Boleslawski E; Pancré V; de Launoit Y; Calmus Y; Conti F; Delhem N Transplant Proc; 2012 Nov; 44(9):2834-9. PubMed ID: 23146536 [TBL] [Abstract][Full Text] [Related]
15. Dyslipidemia can reduce the immunosuppressive effects of cyclosporine. Pozzetto U; Citterio F; Fioravanti G; Navarra P; Boccalini F; Castagneto M Transpl Immunol; 2008 Feb; 18(4):349-51. PubMed ID: 18158122 [TBL] [Abstract][Full Text] [Related]
16. The synergism of brequinar sodium and cyclosporine used in combination to prevent cardiac allograft rejection in the rat. Cosenza CA; Cramer DV; Eiras-Hreha G; Cajulis E; Wang HK; Makowka L Transplantation; 1993 Sep; 56(3):667-72. PubMed ID: 8212165 [TBL] [Abstract][Full Text] [Related]
17. The additive effect of certain drugs on the cyclosporine A inhibition of human T-cell proliferation. Studies using theophyllamine, warfarin, verapamil and dipyridamol. Bruserud O APMIS; 1990 Dec; 98(12):1070-6. PubMed ID: 2282202 [TBL] [Abstract][Full Text] [Related]
18. Immunosuppressants suppressing signal 2 of T-cell activation enable CsA to induce operational transplantation tolerance in a strongly immunogenic heart allograft model in rats. Lin Y; Goebels J; Vandeputte M; Waer M Transplant Proc; 1996 Apr; 28(2):977-8. PubMed ID: 8623485 [No Abstract] [Full Text] [Related]
19. Additive effects of calcium antagonists on cyclosporin A-induced inhibition of T-cell proliferation. Marx M; Weber M; Merkel F; Meyer zum Büschenfelde KH; Köhler H Nephrol Dial Transplant; 1990; 5(12):1038-44. PubMed ID: 2151399 [TBL] [Abstract][Full Text] [Related]
20. A novel immunosuppressant, IR-1116, which has a different biological mechanism from that of cyclosporine A. Matsumoto S; Marui S; Shiho O; Tsukamoto K; Yoshimura N; Oka T Eur J Immunol; 1993 Sep; 23(9):2121-8. PubMed ID: 8370395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]